Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$0.92 USD
-0.03 (-2.77%)
Updated Apr 26, 2024 10:28 AM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
RPID 0.92 -0.03(-2.77%)
Will RPID be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RPID
Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates
Other News for RPID
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bad News for Rapid Micro Biosystems, Inc. Class A Stock: This New Risk Has Been Added